Voyageur Pharmaceuticals Ltd. (OTCMKTS:VYYRF – Get Free Report)’s share price rose 1,150% during mid-day trading on Friday . The company traded as high as $1.03 and last traded at $1.00. 46,500 shares were traded during mid-day trading, an increase of 104% from the average daily volume of 22,784 shares. The stock had previously closed at $0.08.
Voyageur Pharmaceuticals Price Performance
The company’s 50 day moving average is $0.12 and its 200 day moving average is $0.10.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals, Inc is a biopharmaceutical company specializing in advanced drug-delivery technologies and contract development services. The company focuses on formulating and optimizing therapeutic compounds to enhance stability, bioavailability and controlled-release properties. By leveraging proprietary polymer- and lipid-based delivery platforms, Voyageur aims to partner with pharmaceutical and biotechnology firms to address formulation challenges in high-value therapeutic areas, including oncology, endocrinology and central nervous system disorders.
The company’s core offerings include formulation development, analytical testing, preclinical evaluation and small-scale manufacturing support.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
